Top 3 Health Care Stocks That May Explode In Q4
Top 3 Health Care Stocks That May Explode In Q4
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
在医疗保健板块中，最被超卖的股票提供了一个投资于被低估公司的机会。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
相对强弱指数（RSI）是一个动量指标，它比较股票在价格上涨天数的强度与价格下跌天数的强度。与股票的价格走势相比，它可以让交易者更好地了解股票在开空期的表现。当RSI低于30时，通常认为资产被超卖，依据Benzinga Pro的说法。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是该板块中最新的主要被低估的股票名单，它们的RSI接近或低于30。
Silence Therapeutics PLC – ADR (NASDAQ:SLN)
Silence Therapeutics PLC – ADR (纳斯达克:SLN)
- On Dec. 10, Chardan Capital analyst Keay Nakae maintained Silence Therapeutics with a Buy and maintained a $55 price target. The company's stock fell around 41% over the past month and has a 52-week low of $5.81.
- RSI Value: 26.72
- SLN Price Action: Shares of Silence Therapeutics fell 3.4% to close at $6.51 on Tuesday.
- Benzinga Pro's real-time newsfeed alerted to latest SLN news.
- 12月10日，Chardan Capital分析师Keay Nakae维持对Silence Therapeutics的买入评级，并设定55美元的目标价。该公司的股票在过去一个月内下跌了约41%，并且52周低点为5.81美元。
- 相对强弱指标(RSI)值：26.72
- SLN价格动态：Silence Therapeutics的股票在周二下跌3.4%，收于6.51美元。
- Benzinga Pro的实时新闻提醒了最新的SLN资讯。
ModivCare Inc (NASDAQ:MODV)
ModivCare公司（纳斯达克：MODV）
- On Nov. 6, ModivCare posted weaker-than-expected quarterly results. "This quarter has demonstrated positive momentum, reflected in both operational enhancements and strengthened relationships, even amid shifts in the broader healthcare market. We delivered solid third-quarter results, reporting $43 million of adjusted EBITDA and a 2% increase in consolidated revenue, driven primarily by 5% growth in our personal care services segment," stated L. Heath Sampson, President and CEO. The company's stock fell around 26% over the past five days and has a 52-week low of $11.00.
- RSI Value: 28.52
- MODV Price Action: Shares of ModivCare fell 11.4% to close at $14.10 on Tuesday.
- Benzinga Pro's charting tool helped identify the trend in MODV stock.
- 11月6日，ModivCare发布了低于预期的季度业绩。"本季度展示了积极的势头，反映在运营改进和增强的关系中，即使在更广泛的医疗保健市场发生变化的情况下。我们交出了稳固的第三季度业绩，报告调整后的EBITDA为4300万，以及营业收入增长2%，主要得益于个人护理服务板块5%的增长，"L. Heath Sampson，总裁兼首席执行官表示。该公司的股票在过去五天内下跌了约26%，且52周最低为11.00美元。
- 相对强弱指数（RSI）值：28.52
- MODV价格走势：ModivCare的股票在周二收盘时下跌了11.4%，报14.10美元。
- Benzinga Pro的图表工具帮助识别MODV股票的趋势。
Olema Pharmaceuticals Inc (NASDAQ:OLMA)
Olema Pharmaceuticals公司（纳斯达克：OLMA）
- On Dec. 10, Olema Oncology presented updated clinical results for Palazestrant in combination with Ribociclib at the San Antonio Breast Cancer Symposium. The company's stock fell around 37% over the past five days and has a 52-week low of $6.08.
- RSI Value: 23.69
- OLMA Price Action: Shares of Olema Pharmaceuticals fell 4.7% to close at $6.14 on Tuesday.
- Benzinga Pro's signals feature notified of a potential breakout in OLMA shares.
- 在12月10日，Olema Oncology在圣安东尼奥乳腺癌研讨会上展示了Palazestrant与Ribociclib联合使用的最新临床结果。该公司的股票在过去五天内下跌了约37%，并且52周低点为6.08美元。
- RSI值：23.69
- OLMA价格动态：Olema Pharmaceuticals的股票在周二下跌了4.7%，收盘价为6.14美元。
- Benzinga Pro的信号功能通知OLMA股票可能会突破。
Read This Next:
接下来请阅读：
- Top 2 Utilities Stocks That Could Sink Your Portfolio This Quarter
- 本季度可能会使您的投资组合下滑的前两名公用事业股票
